A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD

Clinical trial NCT05686044 · COMPLETED

Trial details

NCT number: NCT05686044
Sponsor: Annovis Bio Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2023-04-01
Primary completion: 2024-02-13
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.